http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008195717-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef1d7ffaf9ca816bad43f580bc6e496
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2008-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_456b6123b7da6f7fd689da9f738268c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86c0aa45dd389815b50de52fef1bf8b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f670ded89a5b4099822894034783d933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be35453033a987715251f562c6442676
publicationDate 2008-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008195717-A
titleOfInvention Transdermal fluid
abstract It is useful for the treatment or prevention of cancer or tumors, inflammatory disorders, especially breast cancer, and has no side effects as seen with hormonal drugs such as tamoxifen or anastrozole for the treatment of breast cancer, which are commercially available antiestrogens. Provide highly effective drugs. A transdermal fluid containing one or more of α-tocotrienol, and / or β-tocotrienol, and / or γ-tocotrienol and / or δ-tocotrienol, preferably δ-tocotrienol, or derivatives thereof. The liquid can be used in combination with a known medicine or alone. [Selection] Figure 1
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012506426-A
priorityDate 2007-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006045114-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005115376-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002308768-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526705-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226592982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226592981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6538275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282348

Total number of triples: 43.